For the quarter ended March 2025, Healthpeak (DOC) reported revenue of $702.89 million, up 15.9% over the same period last year. EPS came in at $0.46, compared to $0.01 in the year-ago quarter.
The reported revenue represents a surprise of +0.98% over the Zacks Consensus Estimate of $696.06 million. With the consensus EPS estimate being $0.46, the company has not delivered EPS surprise.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Healthpeak performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Resident fees and services: $148.93 million compared to the $147.18 million average estimate based on three analysts.
- Revenues- Rental and related revenues: $538.14 million compared to the $527.49 million average estimate based on three analysts. The reported number represents a change of +16.5% year over year.
- Revenues- Interest income and other: $15.82 million versus $16.97 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +175.1% change.
- Net Earnings per Share (Diluted): $0.06 versus the four-analyst average estimate of $0.05.
View all Key Company Metrics for Healthpeak here>>>
Shares of Healthpeak have returned -7.3% over the past month versus the Zacks S&P 500 composite's -5.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Healthpeak Properties, Inc. (DOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
